Angela Macfarlane

A dynamic leader and inspiring role model, Angela currently serves as CEO of ForSight Labs, CEO of Voyant Biotherapeutics and is an active manager and mentor in the Ferolyn Fellowship program.

Despite her tremendous success in the medical technology arena, her path in the field hasn’t been a traditional one, as she kicked off her career as a judicial extern for the United States District Court. However, her interest in early-stage startups soon led her to the realization that medtech companies were the ones in the greatest need of a strong IP strategy, which led to her first job with VidaMed (Medtronic).

Angela later joined AneuRx, where she first met Dr. Fogarty who imparted his successful approach to innovation and minimally invasive surgery. This forged the notion and motto that “patients are waiting,” which sparked her interest in broadening her experience in medtech.

She continued working with Dr. Fogarty, serving as technology counsel where she participated in the formation and/or development of nine companies, and later rounded out her experience as chief technology counsel for The Foundry.

Having honed many of the skills needed to spearhead a company, she founded ForSight Labs, an ophthalmic incubator formed in 2005 in partnership with Dr. Eugene de Juan, Jr., MD, and The Foundry. The portfolio launched six companies and collectively raised over $200 million in capital, returning over $550 million to date with an additional $550 million in milestones.

Her ability to see opportunities and possibilities at every corner, passion for the success of others and motivation for creating a community of innovation is what led her to join the Fogarty Innovation board.

An inventor on over 25 U.S. patents, Angela received her Bachelor of Arts in business administration from San Francisco State University and her J.D. from Golden Gate University School of Law.